CoChat

Testosterone Replacement Therapy Outcomes Among Opioid Users: The Testim Registry in the United States (TRiUS)

Blick, Gary, Khera, Mohit, Bhattacharya, Rajib K., Nguyen, Dat, Kushner, Harvey, Miner, Martin M. · 2012 · Pain Medicine
Cited by 45

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: Among patients with hypogonadism-associated comorbidities, opioid users have the highest incidence of hypogonadism. Data from the Testim Registry in the United States were analyzed to determine the efficacy of testosterone replacement therapy in opioid users vs nonusers. DESIGN: Prospective, 12-month observational cohort registry. SUBJECTS: Hypogonadal men (N = 849) prescribed Testim (but not necessarily testosterone replacement) for the first time. INTERVENTIONS: Testim 1% testosterone gel (5-10 g/day). OUTCOME MEASURES: Total and free testosterone, sex hormone-binding globulin, prostate-specific antigen, sexual function, mood/depression, and anthropometric data were assessed. Changes from baseline were analyzed using repeated measures mixed-effects analysis of variance; multiple linear regressions of changes in testosterone levels with sexual function, mood, and opioid use were computed. RESULTS: 90/849 patients (10.6%) reported opioid use at baseline; 75/90 (83%) used opioids for ≥ 30 days prior to baseline. Baseline total testosterone and prostate-specific antigen were not statistically different between opioid users and nonusers; there was a trend for higher sex hormone-binding globulin (P = 0.08) and lower free testosterone (P = 0.05) in opioid users. After 1 month, both opioid users and nonusers had significant (P < 0.001) increases in total and free testosterone, which continued through 12 months. Sexual function and mood improved significantly in both opioid users and nonusers over 12 months, and significantly correlated with change in total testosterone. CONCLUSIONS: Testosterone replacement therapy increased serum testosterone in hypogonadal opioid users and nonusers alike. The data suggest that with testosterone replacement, hypogonadal opioid users might be expected to have similar improvements in sexual function and mood as opioid nonusers.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1526-4637.2012.01368.x

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 14 references

Research works printed but not linked: 16

  1. 10.1210/jc.85.6.2215 · DOI · Paper page
  2. 10.1210/jc.2003-030200 · DOI
  3. Tuck, 2009, Testosterone, bone and osteoporosis, Front Horm Res, 37, 123, 10.1159/000176049 · DOI · Paper page
  4. 10.1111/j.1743-6109.2007.00531.x · DOI · Paper page
  5. 10.2164/jandrol.108.007245 · DOI · Paper page
  6. 10.1001/archpsyc.61.2.162 · DOI · Paper page
  7. 10.2165/00002512-200825050-00001 · DOI
  8. 10.3810/pgm.2011.07.2300 · DOI
  9. 10.1016/S0090-4295(99)80304-5 · DOI · Paper page
  10. National Cholesterol Education Program, National Institutes of Health, 2002, Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report, Circulation, 106, 3143, 10.1161/circ.106.25.3143 · DOI · Paper page
  11. 10.1097/00002508-200205000-00002 · DOI · Paper page
  12. 10.1016/S0885-3924(03)00331-2 · DOI
  13. 10.1111/j.1743-6109.2007.00702.x · DOI · Paper page
  14. 10.1186/1744-8069-6-69 · DOI
  15. 10.1210/jc.2002-021058 · DOI · Paper page
  16. Dean, 2005, Long-term effects of Testim® 1% testosterone gel in hypogonadal men, Rev Urol, 7, 87

Cited by

See all 45

Metadata

Authors
Blick, G., Khera, M., Bhattacharya, R. K., Nguyen, D., Kushner, H., & Miner, M. M.
Venue
Pain Medicine
Published
2012-05
Volume
13
Issue
5
Pages
688-698
ISSN
  • 1526-2375 (ISSN-L)
  • 1526-4637
OpenAlex
W1786706016
Cited by
45
References
14
FWCI
2.53
Type
journal article
Language
en
Open access
closed
Licence
doi.wiley.com/10.1002/tdm_license_1 (tdm, 1218 d)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Testosterone Replacement Therapy Outcomes Among Opioid Users: The Testim Registry in the United States (TRiUS). https://app.cochat.ai/papers/10.1111/j.1526-4637.2012.01368.x
The paper
Blick, G., Khera, M., Bhattacharya, R. K., Nguyen, D., Kushner, H., & Miner, M. M. (2012). Testosterone Replacement Therapy Outcomes Among Opioid Users: The Testim Registry in the United States (TRiUS). Pain Medicine. https://doi.org/10.1111/j.1526-4637.2012.01368.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.